The polymerase chain reaction (PCR) was used to develop a test for the detection of Mycoplasma mycoides subspecies mycoides SC in the tissues of animals infected with contagious bovine pleuropneumonia (CBPP). Two sets of primers were designed; one set (MC323/MC358) to amplify a ~1.5-kbp DNA fragment from all the members of the M. mycoides 'Cluster' and the other set (MM450/MM451) specifically amplified a 574-bp DNA fragment from M. mycoides subspecies. The PCR products could be differentiated further by digestion with the restriction enzyme AsnI. Enzyme digestion of amplification products from M. m. mycoides SC produced 2 fragments, whereas the other 2 M. mycoides subspecies, M. m. mycoides LC and M. m. capri, produced 3 fragments. This test was shown to be very sensitive, being able to detect between 10 and 100 organisms. Cattle were experimentally infected with the Gladysdale strain of M. m. mycoides SC, and samples of serum and mucus were taken periodically, as were postmortem samples of lung, lymph node, pleural fluid, synovial fluid, and tracheal swabs. Complement fixation test on serum samples, culture of postmortem tissues, and histopathologic examination confirmed disease. DNA was extracted from postmortem samples and amplified by PCR using primers MM450 and MM451. Digestion of products using AsnI allowed the specific identification of M. m. mycoides SC. This test could confirm CBPP in 48 hours and was thus capable of giving a more rapid result than the traditional methods of culture, isolation, and identification using biochemical and serological techniques.
J. B. Bashiruddin, T. K. Taylor, A. R. Gould Contagious bovine pleuropneumonia (CBPP) is caused by the small colony form of Mycoplasma mycoides subspecies mycoides (MmmSC) . Although other bovids are also affected, CBPP is a disease mainly of domestic cattle and is characterized in typical cases by a fibrinous interstitial pneumonia and pleurisy. Clinical signs of the disease are attributable to lesions that develop in the thorax, where large areas of the lungs may be involved. The disease was once widespread but has gradually been eradicated from most developed countries; it was eradicated from the USA in 1892, and the last case in Australia was reported in 1967. The disease is now mainly confined to the African continent, although there have been a number of recent outbreaks reported in southern Europe.
Provisional diagnosis of CBPP can be made on the basis of clinical and pathological findings. However, the disease can be confused with bronchopneumonia or pleuropneumonia resulting from mixed infections caused either by viruses or bacteria such as Pasteurella sp.
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Received for publication February 1, 1994. methods, including culture and serology, although each can have its disadvantages. These mycoplasmas are slow growing, and culture can take up to 3 weeks for isolation and identification. The detection of antigen in lesion material using positive sera is an indirect test that detects the surface antigen galactan and is rapid but not very sensitive. 2 In clinical cases of CBPP, circulating antibodies can be demonstrated by the complement fixation test (CFT) or the enzyme-linked immunosorbent assay (ELISA). The CFT is a very specific test with a very low number of false-positive results, but it is not very sensitive. 11 The ELISA is claimed to be more sensitive than the CFT. 9 The CFT can detect nearly 100% of acute cases of CBPP, but the rate of the detection of chronically infected animals is much lower, at 72%. The ELISA is also less sensitive for the detection of the low levels of circulating antibodies usually found in chronically infected animals.
The polymerase chain reaction (PCR) has been shown by others to be an extremely sensitive and specific technique capable of amplification factors between 10 5 and 10 6 , and it has been used in our laboratory for the diagnosis of CBPP. 8 A fragment of the genome of M. mycoides subspecies capri, CAP-21, used as a gene probe was able to differentiate the 6 mycoplasmas that comprise the M. mycoides 'Cluster' into 4 groups. It was also capable of making specific differentiation between the 2 types of M. m. mycoides. 13 The 1.5-kbp CAP-21 fragment was sequenced, and the data were used to design oligonucleotide primers for PCR. Comparison of sequences for each member of the M. mycoides 'Cluster' corresponding to CAP-21 showed 2 regions of significant variability. 14 Two oligonucleotide primers were derived from the sequences of those regions. When used in the PCR, they only detected mycoplasmas belonging to M. mycoides. Using these primers, a rapid PCR test was developed for the diagnosis of CBPP directly from clinical material or for the confirmation of cultured Mmm SC.
Materials and methods

Organisms
Representative strains of each member of the M. mycoides 'Cluster' were obtained from the collection of G. S. Cottew held at our laboratory: Mmm SC (strain Gladysdale), Mmm LC (strain Y Goat), M. m. capri (strain ZZ), F38 mycoplasma original isolate, M. capricolum (strain California kid), and bovine group 7 mycoplasma (strain N29). Other isolates of Mmm SC tested were V5, CF1, DVZ, EMB, and R575 from Australian cattle; PG1, the type strain; KH 3 J from Sudan; and O Goat, P Goat, VOM, and Custer from goats. The Mmm LC isolates OSB42, EZG, and F30 are from African goats; COV2 is from Turkish goats; and KH1, LB2, 801, 74/ 2488, and 78/441 are Australian isolates. The M. m. capri isolates PG3, BQT, YC, and N108 were used. Other organisms used were Escherichia coli, Pasteurella multocida, Acholeplasma laidlawii, Mycoplasma hyorhinis, M. arginini, and M. orale NCTC 10112. Where the strain was known, it is designated; otherwise, organisms used were laboratory strains.
All strains of mycoplasmas were maintained on a modified mycoplasma agar (MA), subcultured weekly, and incubated at 37 C in 5% CO 2 .6 For the isolation of DNA, organisms were grown in a mycoplasma broth (MB) containing 20% pig serum. a A single colony of the organism grown on MA was inoculated into 200 ml of broth and incubated with constant agitation at 37 C for 3-4 days. Cells were harvested aseptically by centrifugation at 10,000 x g for 30 min at 4 C and washed once in cold phosphate-buffered saline and the pellet was used immediately or stored at -80 C until required.
Polymerase chain reaction
Oligonucleotide primers were chemically synthesized b for use in PCR experiments. The M. mycoides 'Cluster'-specific primers MC323 and MC358 were derived from the sequence of CAP-21 and amplify a DNA fragment homologous to the CAP-21 probe. The choice of M. mycoides species-specific primers MM450 and MM451 was a consequence of the comparison of sequences from the M. mycoides 'Cluster' homologous to CAP-21 and were designed to exclude the other closely related organisms. 13 The sequences, relative positions, and directions of these primers are given in Table 1 . Development and optimization of the PCR test was done using both primer sets MC323/MC358 and MM450/MM451 and genomic DNA from all representative members of the M. mycoides 'Cluster'. Five microliters of template DNA was amplified for 30 cycles in a total volume of 50 µl. The reaction mixture consisted of 10 mM Tris-HC1 (pH 8.3) 50 mM KCl, 1.5 mM MgCl 2 , 0.001% (w/v) gelatin, 200 µM each dATP, dGTP, dTTP, and dCTP, and 1.5 U of Taq polymerase. c Each primer was used at 50 pmoles total per reaction. The optimal amplification cycle for both primer sets consisted of denaturation at 94 C for 1 min, annealing at 50 C for 1 min, and extension at 72 C for 2 min and was performed on a thermal cycler. c Five microliters of PCR product was then electrophoresed through a 0.8% agarose gel, and the PCR products were visualized by staining with ethidium bromide. The DNA markers used were /HindIII d fragments of size 23.1, 9.4, 6.6, 4.4, 2.3, 2.0, 0.5, and 0.1 kbp and pUC19/HpaII e fragments of size 0.501, 0.489, 0.404, 0.331, 0.242, 0.190, 0.147, 0.111, 0.110, 0.067, 0.034, 0.026 kbp.
Specificity
DNA was extracted from members of the M. mycoides 'Cluster', other mycoplasmas (M. arginini, M. orale, M. hyorhinis, and A. laidlawii), and bacteria E. coli and P. multocida, and PCR was carried out with primers MC323 and MC358 using the conditions above. Similar tests were done using primers MM450 and MM451. CAP-21 DNA was included as a control.
Sensitivity
An overnight culture of Mmm SC strain Gladysdale in MB was grown in a shaking incubator. Growth was determined by optical density measurements of the culture at 625 nm. Ten milliliters of the culture was centrifuged at 13,000 x g, the supernatant was discarded, and the pellet was resuspended in 10 ml of low Tris (10 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid [EDTA]). One milliliter of the resuspended culture was diluted in 9 ml of low Tris and then serially diluted to a final dilution of 10 -8 DNA from 100 µl of each dilution was then extracted and tested by PCR using both sets of primers MC323/MC358 and MM450/MM451. The number of organisms per milliliter in the overnight culture was determined by subculture in triplicate of 100 µl of the 10 -6 , 10 -7 , and 10 -8 dilutions on MA plates.
DNA extraction from cultures
DNA was prepared from 100 µl suspensions by the addition of 0.02 mg of proteinase K f and incubated at 56 C for 15 min and then at 37 C for 45 min. The DNA was extracted by adding 200 µl of phenol/chloroform/isoamyl alcohol (25: 24:1). The mixture was vortexed and centrifuged at 13,000 x g for 10 min. DNA was precipitated by adding sodium acetate to 0.3 M and 600 µl of ethanol at -80 C for 3 hr and then centrifuged at 13,000 x g for 10 min. The supernatant was decanted, and pelleted DNA was washed with 80% ethanol, dried under vacuum, and resuspended in 20 µl of H 2 O. PCR was then done on 5 µl of template DNA.
Animals
Two cattle (cow 1 and cow 2) were infected with Mmm SC strain Gladysdale by endobronchial intubation. Each animal was sedated with 1.5 ml of xylazine hydrochloride, g and a tube was inserted into the mouth and pushed down to the lungs. Approximately 20 ml of supernatant from an homogenate of lung tissue from a previously infected animal was then inoculated into the animal's lungs via the tube. 7 Prior to and after inoculation, nasal swabs, blood samples, and rectal temperatures were taken at 3-4-day intervals from cow 1. Serum samples were used in a standard CFT. 2 At postmortem, swabs of tracheal exudate, pleural fluid, and joint fluid and lung and lymph node tissue samples were collected from both cows for PCR, culture, and histology. Culture has shown that infective material usually contains approximately 10 7 organisms/ml.
Application of PCR to clinical samples
Preparation of clinical samples. Approximately 1 g of tissue was added to 1 ml of low Tris and homogenized. h Ten microliters of homogenate was added to 90 µl of low Tris, 100 µl of 50 mM Tris-HCl, 20 mM EDTA, 0.7% N-lauroylsarcosine, and 10 µl 10 mg/ml proteinase K. The digest was incubated at 56 C for 15 min and then at 37 C for 45 min. The solution was then extracted with 200 µl phenol/ chloroform/isoamyl alcohol (25:24:1) and centrifuged at 13,000 x g for 10 min. The supernatant was transferred to a fresh tube, and DNA was precipitated by adding 20 µl 3 M sodium acetate (pH 5.3) and 500 µl ethanol. Tubes were left at -80 C for 3 hr; DNA was then centrifuged at 13,000 x g for 10 min, and supernatant was removed. Pelleted DNA was washed in 80% ethanol and centrifuged at 13,000 x g for 10 min. Supernatant was removed, and the DNA pellet was dried under vacuum. DNA was resuspended in 5 µl H 2 O for use as template for PCR.
Digestion of products by restriction endonuclease. A 45 µl aliquot of PCR product was treated with 0.02 mg of proteinase K for 30 min at room temperature. The product was extracted with 100 µl phenol and centrifuged at 13,000 x g for 10 min. The upper aqueous phase was transferred to a new tube, and DNA was precipitated by adding 4 µl1 3.5 M sodium acetate and 120 µl of ethanol. Precipitation was at -80 C for 1 hr. The DNA was pelleted by centrifugation at 13,000 x g for 10 min, washed with 80% ethanol, dried under vacuum, and resuspended in 15 µl H 2 O.
DNA was digested with 5 U of AsnI restriction endonuclease f using buffer B supplied with the enzyme in a total volume of 20 µl for 1.5 hr at 37 C. The digests were then electrophoresed in a 3.0% agarose gel. i Gels were run at 70 V for 1.5 hr, and DNA was stained with ethidium bromide and visualized under UV light.
Results
PCR amplification of DNA from cultures. The oligonucleotide primers MC323 and MC358 are located at the 5' and 3' ends of the CAP-21 sequence, respectively, and flank a DNA fragment of about 1.5 kb. These primers were used in PCR amplification of genomic DNA from members of the M. mycoides 'Cluster' and with DNA from the other mycoplasmas and bacteria. Single bands of expected size were seen after agarose gel electrophoresis and ethidium bromide staining of the PCR products from all members of the M. mycoides 'Cluster' and the CAP-21 DNA; the other mycoplasmas and bacteria did not produce amplification products (Fig. 1) . At the reaction conditions described, the primers MC323 and MC358 specifically amplified DNA from the M. mycoides 'Cluster'.
A comparison of sequences homologous to the CAP-21 probe for each member of the M. mycoides 'Cluster' showed 2 regions of significant sequence variability. Two oligonucleotide primers, MM450 and MM451, The number of mycoplasma organisms in serial dilution was determined by culture on MA plates. DNA extracted from a 100-µl sample of each dilution was amplified. After electrophoresis and ethidium bromide staining, products 574 bp in size were seen in lanes corresponding to the dilutions containing 10-100,000 organisms. Lanes: M, /HindIII markers; C, DNA extracted from Mmm SC, used as a control. from M. capricolum, the F38 mycoplasma, bovine group 7 mycoplasmas, or the other mycoplasmas and bacteria (Fig. 2) . Not only were the primers MM450 and MM451 specific for the M. mycoides subspecies but they also functioned with all of the strains of organisms belonging to this group.
The sensitivities of both sets of primers, MC323/ MC358 and MM450/MM451, were tested for their ability to detect genomic DNA extracted from a dilution series of cultured organisms. The limit of detection using ethidium bromide staining of amplified DNA in agarose gel electrophoresis for both sets of primers was 10-100 organisms (Fig. 3) .
PCR amplification of DNA from clinical samples.
To assess the suitability of this test for clinical samples, animals were inoculated with the Gladysdale strain of Mmm SC. The animals were observed for the appearance of clinical signs of pneumonia and monitored serologically for the presence of antibodies by CFT. Subsequent histopathological investigations and culture of Mmm SC from tissues and fluids collected at postmortem confirmed disease.
One animal (cow 1) appeared normal during the course of this experiment and rectal temperatures did not vary from 39 C; the asymptomatic presentation in experimentally inoculated but pathologically ill cattle has been observed previous1y. 1 The animal seroconverted to a titer of 1 + at 1:84 days postinoculation (PI) and reached 4+ at 1:128 at euthanasia 15 days PI, indicating current infection (Table 2) . Total DNA was extracted from mucus from the nasal swabs, and PCR was carried out using primer set MC323/MC358; bands of expected size were present in samples from the day 1 PI (Fig. 4) .
Postmortem samples (cow 1, 2) were also taken for testing by PCR. Primer set MM450/MM451 produced a single PCR product of the expected size from samples including lung tissues, lymph nodes, pleural fluid, synovial fluid, and tracheal swabs from both animals (Fig. 5 ). Lung tissue from an uninfected cow was used as a negative control. These primers have also been SC in the region flanked by the oligonucleotides MM450 and MM451. The digestion with AsnI of PCR products from Mmm SC produced 2 visible digestion fragments, whereas M. m. capri and Mmm LC both produced 3 visible digestion products. These enzyme patterns were consistent across all strains of the M. mycoides subspecies. Strains Gladysdale, Y Goat, and ZZ were used as controls to compare the PCR products from clinical material. The restriction products of amplified DNA from tissue samples of infected cows were identical to those from genomic DNA of Mmm SC (Fig. 6 ).
Discussion
The significance of CBPP as a disease of great economic importance has been reinforced with outbreaks of CBPP occurring in Europe. Part of the problem of CBPP control has been the difficulty in disease diagnosis, and this may be attributable to a number of factors. It may be that the majority of animals infected with CBPP do not show clinical signs despite the presence of lung lesions, and this poses a major problem in surveillance. 10 Serology using the standard CFT does not distinguish infection with LC and SC strains of M. m. mycoides. A detection rate of only 72% of chronic cases has always posed the threat of inadvertent introduction of the organism into disease-free areas. Culture has not always been a successful epidemiological surveillance method, especially when animals have been treated with antibiotics, corticosteroids, or both.
One PCR test utilized primers MC323 and MC358, which were derived from each end of the sequence of the DNA probe CAP-21 of M. m. capri strain ZZ. 13 Another set of primers, MM450 and MM451, were selected after comparisons of homologous regions for all members of the M. mycoides 'Cluster' and reacted specifically with the M. mycoides subspecies. 14 Amplification products were observed from all 5 isolates of M. m. capri, 12 isolates of Mmm SC, and 11 isolates of Mmm LC. When digested with AsnI, simple consistent patterns distinguished Mmm SC from the others and made interpretation very easy. This test may have broad isolate sensitivity, as suggested by the fact that the organisms used here were wide-ranging both geographically and in terms of the hosts from which they were isolated. and insensitivity. Tests may be simplified further and made more rapid by the development of less laborious methods of DNA extraction and product detection. Use as a diagnostic tool requires validation by application in the field for robustness as a screening test and as a potential means of detecting chronic carriers of infection.
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